Intuor Technologies, LLC is a privately held company creating products reflecting our Visionary Innovation^TM mission through the application of engineering principles to optical and ophthalmic scientific concepts. Based on preliminary testing, our FDA cleared flagship product, CATS Tonometer Prism^TM, has potential to greatly enhance clinical care through a reduction in errors related to intraocular eye pressure (IOP) measurements. Accurate, repeatable IOP measurements are critical for the treatment of all ocular disease processes, including glaucoma, as well as for routine screening exams by any eye care professional. For more information [click here].

TUCSON, Arizona, March 22, 2018 - Intuor Technologies is pleased to announce that the FDA has cleared their CATS Tonometer™ Reusable Prism for marketing and sales in the United States. Intuor plans to file future CATS Tonometer™ prism FDA and CE Mark submissions for a disposable version and expanded claims.

"Based on numerous scientific studies, the CATS Tonometer Prism™ our flagship product, has the potential to greatly enhance clinical care through a reduction in errors related to intraocular eye pressure (IOP) measurements," stated Sean McCafferty, MC FACS, Intuor Technologies CEO and President. "Measurement of IOP is not only critical to the accurate diagnosis of ocular disease but is also a necessary guide to effective treatment strategies."